Saulnier Sholler G, Bergendahl G, Lenox S, Zage P, Roberts W, Kraveka J, Eslin D, Kaplan J, Higgins T, Ferguson T.  A phase I trial of TPI-287 as a single agent and it combination with temozolomide in relapsed neuroblastoma or medulloblastoma. June 2010 ASCO Annual Meeting, Chicago, IL

Currier E, Illenye S, Ashikaga T, Lescault P, Bond J and Saulnier Sholler G. Bortezomib and HDAC inhibitor PCI-24781 combination therapy for Neuroblastoma. April 2010 AACR Annual Meeting, Washington DC 

Saulnier Sholler G, Illenye S, Warzynski M, Brown RE, Lescault PJ, Koto K, Dorf L, Bond J.  Neuroblastoma: a spectrum of cells isolated from bone marrow of patients. May 2009 ASCO Annual Meeting, Orlando, FL

Dorf L,  Brard L, Koto K, Illenye S, Ashikaga T, Singh R, Kim K, Saulnier Sholler G.  Increased cytotoxicity with nifurtimox and rapamycin combination therapy in neuroblastoma. April 2009, AACR Annual Meeting, Denver, CO

Koto K, Brard L, Bosenberg M, Dorf L, Illenye S, Singh R, Kim K, Saulnier Sholler G. RKS-2-62: A Novel Therapy for Medulloblastoma with activity in vitro and in vivo.  June 2008 ISPNO Annual Meeting, Chicago, IL

Saulnier Sholler G, Ferguson W, Brard L, Johnson G, Heath B, Bingham P, Ashikaga T, Kamen B, Homans A.  A Phase I study of nifurtimox in patients with relapsed/refractory neuroblastoma.  June 2008 ASCO Annual Meeting, Chicago, IL

Dorf L, Brard L, Koto K, Bosenberg M, Illyene S, Singh R, Kim K, Saulnier Sholler G.  A Novel Drug RKS-2-62 Is Cytotoxic To Neuroblastoma In Vitro And In Vivo.   May 2008 ANR Meeting, Chiba, Japan

Koto K, Brard L, Bosenberg M, Dorf L, Illenye S, Singh R, Kim K, Saulnier Sholler G. Antitumor activity of Nifurtimox and MT-19C alone and in combination in medulloblastoma in vitro and in vivo    AACR 2008 Annual Meeting, San Diego, CA

Dorf L, Brard L, Koto K, Bosenberg M, Illyene S, Singh R, Kim K, Saulnier Sholler G. RKS-2-62 is more effective and less toxic than its parent drug Nifurtimox for Neuroblastoma.  AACR 2008 Annual Meeting, San Diego, CA

Dorf L, Kalkunte S, Singh R, Brard L, Saulnier Sholler G, Sulforaphane is cytotoxic to neuroblastoma both in vitro and in vivo. May 2007 PAS/SRP/American Society of Pediatric Hematology/Oncology Conference, Toronto ON (Poster Presentation)